What are the safe and effective contraceptive options for women after pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe and Effective Contraceptive Options After Pregnancy

Long-acting reversible contraceptives (LARCs), including intrauterine devices (IUDs) and implants, are the most effective contraceptive options for women after pregnancy and should be considered first-line methods due to their superior efficacy and convenience in the postpartum period. 1

Timing of Contraception Initiation by Method

For Breastfeeding Women:

  1. LARC Methods (IUDs and Implants)

    • Can be inserted immediately postpartum (within 10 minutes of placental delivery) or any time thereafter 1
    • Copper IUD: Can be inserted immediately after delivery (US MEC 1) 1
    • Levonorgestrel IUD: Can be inserted immediately after delivery (US MEC 2) 1
    • Implant: Can be inserted any time postpartum (US MEC 2 if <1 month, US MEC 1 if ≥1 month) 1
    • No negative effects on breastfeeding have been demonstrated 1
  2. Progestin-only Pills

    • Can be started immediately postpartum (US MEC 2) 1
    • Require taking at the same time daily (within 3 hours) 1
  3. Combined Hormonal Methods (Pills, Patch, Ring)

    • Should NOT be used during first 3 weeks postpartum (US MEC 4) 1
    • Generally should not be used during 4th week postpartum (US MEC 3) 1
    • After 4-6 weeks postpartum, can be used if no additional VTE risk factors (US MEC 2) 1
    • Women with VTE risk factors generally should not use combined hormonal methods 4-6 weeks after delivery (US MEC 3) 1

For Non-Breastfeeding Women:

  1. LARC Methods (IUDs and Implants)

    • Can be inserted immediately postpartum or any time thereafter 1
    • No waiting period required 1
  2. Progestin-only Pills

    • Can be started immediately postpartum (US MEC 1) 1
  3. Combined Hormonal Methods (Pills, Patch, Ring)

    • Should NOT be used during first 3 weeks postpartum (US MEC 4) due to increased VTE risk 1
    • From 21-42 days postpartum:
      • Without VTE risk factors: Can be used (US MEC 2) 1
      • With VTE risk factors: Generally should not be used (US MEC 3) 1
    • After 42 days: No restrictions for healthy women (US MEC 1) 1

Effectiveness of Contraceptive Methods

Ranked from most to least effective:

  1. Implant: 0.05% failure rate with typical use 1
  2. Levonorgestrel IUD: 0.2% failure rate with typical use 1
  3. Copper IUD: 0.8% failure rate with typical use 1
  4. DMPA injection: 6% failure rate with typical use 1
  5. Combined hormonal methods (pill, patch, ring): 9% failure rate with typical use 1
  6. Progestin-only pill: Similar to combined pills with perfect use, but more time-sensitive 1

Special Considerations for Immediate Postpartum LARC

Benefits:

  • Immediate contraceptive protection 1
  • Higher continuation rates at 6 months (80% vs 50%) 1
  • Reduces unintended and short-interval pregnancies 1
  • Overcomes barriers of missed postpartum visits and insurance coverage issues 1

Limitations:

  • Higher IUD expulsion rates with immediate postpartum insertion (10% within 10 minutes of placental delivery) compared to interval insertion 1, 2
  • No increased risk of infection, uterine perforation, or bleeding 1

Need for Backup Contraception

  • Implant: If inserted within 5 days of menses starting, no backup needed; otherwise 7 days of backup needed 1
  • IUD: No backup needed if inserted within 5 days of menses starting 1
  • Combined hormonal methods: 7 days of backup needed unless started within first 5 days of menses 3
  • Progestin-only pills: 2 days of backup needed unless started within first 5 days of menses 3
  • Breastfeeding women: No additional contraception needed if <6 months postpartum, amenorrheic, and fully or nearly fully breastfeeding (≥85% of feeds) 1

Contraindications to Specific Methods

Combined Hormonal Methods:

  • First 3 weeks postpartum (all women) 1
  • 3-6 weeks postpartum with VTE risk factors 1
  • Risk factors for VTE include age ≥35 years, previous VTE, thrombophilia, immobility, transfusion at delivery, BMI ≥30 kg/m², postpartum hemorrhage, cesarean delivery, preeclampsia, or smoking 1

IUDs:

  • Distorted uterine cavity, Wilson disease (copper IUD), current breast cancer (levonorgestrel IUD), cervical/endometrial cancer, malignant gestational trophoblastic disease, PID, post-septic abortion, puerperal sepsis, purulent cervicitis, pelvic tuberculosis, or unexplained vaginal bleeding 1

Implants:

  • Current breast cancer 1

Common Pitfalls to Avoid

  1. Delaying contraception initiation: Many women resume sexual activity before the traditional 6-week postpartum visit, risking unintended pregnancy 1

  2. Overestimating breastfeeding as contraception: While exclusive breastfeeding provides some protection (lactational amenorrhea method), it's not fully reliable beyond 6 months or if not exclusively breastfeeding 1

  3. Ignoring VTE risk in the postpartum period: Combined hormonal methods should be avoided in the early postpartum period due to increased thrombosis risk 1

  4. Missing the opportunity for immediate postpartum LARC: Despite higher expulsion rates, immediate postpartum IUD insertion has higher continuation rates than delayed insertion 1

  5. Failing to counsel on backup methods: Additional contraception is needed for most methods if not started within the first 5 days of menses 1, 3

By prioritizing the most effective methods first and considering the timing of initiation based on breastfeeding status and VTE risk factors, healthcare providers can help women choose the safest and most effective contraceptive option after pregnancy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hormonal Contraceptives

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.